Drug Type Monoclonal antibody |
Synonyms STSA 1201, STSA-1201, STSA1201 |
Target |
Action inhibitors |
Mechanism TSLP inhibitors(Thymic stromal lymphopoietin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | China | 04 Aug 2023 |